about
Implementation of 3 T lactate-edited 3D 1H MR spectroscopic imaging with flyback echo-planar readout for gliomas patients3D sensitivity encoded ellipsoidal MR spectroscopic imaging of gliomas at 3T.Multi-channel metabolic imaging, with SENSE reconstruction, of hyperpolarized [1-(13)C] pyruvate in a live rat at 3.0 tesla on a clinical MR scannerWorkshop on reconstruction schemes for magnetic resonance data: summary of findings and recommendations.Classification of phosphorus magnetic resonance spectroscopic imaging of brain tumors using support vector machine and logistic regression at 3T.Considerations in applying compressed sensing to in vivo phosphorus MR spectroscopic imaging of human brain at 3T.Accelerated phosphorus magnetic resonance spectroscopic imaging using compressed sensing.Final Gleason score prediction using discriminant analysis and support vector machine based on preoperative multiparametric MR imaging of prostate cancer at 3T.(1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques.Erratum to: Comparison of the trifecta outcomes of robotic and open nephron-sparing surgeries performed in the robotic era of a single institution.3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil.High-speed 3T MR spectroscopic imaging of prostate with flyback echo-planar encoding.Fast magnetic resonance spectroscopic imaging at 3 Tesla using autocalibrating parallel technique.Unaliasing lipid contamination for MR spectroscopic imaging of gliomas at 3T using sensitivity encoding (SENSE).Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T.Elliptical magnetic resonance spectroscopic imaging with GRAPPA for imaging brain tumors at 3 T.Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.Machine-learning in grading of gliomas based on multi-parametric magnetic resonance imaging at 3T.Identification of IDH and TERTp mutation status using 1 H-MRS in 112 hemispheric diffuse gliomas
P50
Q34440284-33E36ED1-A9F5-4E35-87DF-EE6FAD62657CQ34498041-DC14F23A-DEE2-4FEB-803D-6D98028FEDD0Q36070241-BBC36C66-9C7F-4875-8C9D-A188DE103744Q36339168-A81A36D0-EAA8-4207-A5FB-27824090BEE7Q39062707-A420A594-5E17-4F15-BB36-A7075A74E209Q39202797-B8DA9EAD-15D3-412E-A22B-AB33AAD4C095Q39475816-DC628671-C751-4C66-A4CB-99F18B4DA19FQ41644200-B41CF5F3-748E-418F-9562-A0B27FCFA7B9Q42594149-2E7306D5-9875-4E5F-9C25-4D3A8815D190Q42608122-DC016989-502C-4E88-9A87-BE592FDE0299Q44822572-8F6456CE-5552-458B-AD96-3101FB38C1D2Q45950205-4E480EC5-8541-478C-A9A3-DC2FAFDAF485Q46011861-F9899B43-DF27-4F28-8ACB-BCAC12F07A2EQ46849145-C1AA9E91-44A1-4C6F-B1F3-EA4919FA7C32Q48348165-6F8B8653-3708-4381-B7AC-A2067ACA590FQ48537329-E65A7D8E-C8EF-4D8D-B7E6-1A22A91FBD08Q48623164-2B172B2B-63C5-41F3-A3CA-33B2801D64E2Q55456774-388382E4-9096-46F2-AF6D-E61256BB0E04Q91003580-DB35FE48-BBC1-47F2-9867-CDC3D7141D09
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Esin Ozturk-Isik
@ast
Esin Ozturk-Isik
@en
Esin Ozturk-Isik
@es
Esin Ozturk-Isik
@nl
Esin Ozturk-Isik
@sl
type
label
Esin Ozturk-Isik
@ast
Esin Ozturk-Isik
@en
Esin Ozturk-Isik
@es
Esin Ozturk-Isik
@nl
Esin Ozturk-Isik
@sl
altLabel
Esin Ozturk
@en
prefLabel
Esin Ozturk-Isik
@ast
Esin Ozturk-Isik
@en
Esin Ozturk-Isik
@es
Esin Ozturk-Isik
@nl
Esin Ozturk-Isik
@sl
P1053
K-9771-2018
P106
P2456
P31
P3829
P496
0000-0002-8997-878X